Radioligand Theranostics in the Management of Neuroendocrine Tumors

Pancreas. 2020 May/Jun;49(5):599-603. doi: 10.1097/MPA.0000000000001546.

¹ From the Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, NYU Grossman School of Medicine, NYU Langone Health, New York, NY.
² Division of Endocrinology and Metabolism, Department of Medicine, Strelitz Diabetes and Neuroendocrine Center, Eastern Virginia Medical School, Norfolk, VA.
³ Division of Endocrinology and Metabolism, Department of Medicine.
⁴ Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA.

No abstract available

Publication types